All ATC classes & categories

Weight-loss medicines Medicamentos para perder peso 减肥药 減重藥

Weight-loss medicines

ATC A08 + A10BJ (GLP-1) + A10BX16 (tirzepatide) — antiobesity preparations and GLP-1 weight-loss medicines. GLP-1s also belong to the diabetes class A10; this is a browse-by-indication collection, not a claim of equivalence.
ATC A08 + A10BJ (GLP-1) + A10BX16 (tirzepatida) — preparados antiobesidad y medicamentos GLP-1 para perder peso. Los GLP-1 también pertenecen a la clase de diabetes A10; es una colección por indicación, no una afirmación de equivalencia.
ATC A08 + A10BJ（GLP-1）+ A10BX16（tirzepatide）——传统抗肥胖药与 GLP-1 减重药。GLP-1 同属降糖大类 A10；这里按减重适应症浏览，不代表同效或可互换。
ATC A08 + A10BJ（GLP-1）+ A10BX16（tirzepatide）——傳統抗肥胖藥與 GLP-1 減重藥。GLP-1 同屬降糖大類 A10；這裡按減重適應症瀏覽，不代表同效或可互換。
GLP-1 medicines such as semaglutide, tirzepatide, liraglutide, dulaglutide and exenatide are also listed under Diabetes medicines (A10). The same ingredient appears in both categories by indication — not as an interchangeable alternative.
Los medicamentos GLP-1 (semaglutida, tirzepatida, liraglutida, dulaglutida, exenatida) también figuran en Medicamentos para la diabetes (A10). El mismo principio aparece en ambas categorías por indicación, no como alternativa intercambiable.
司美格鲁肽（semaglutide）、替尔泊肽（tirzepatide）、利拉鲁肽（liraglutide）、度拉糖肽（dulaglutide）、艾塞那肽（exenatide）等 GLP-1 也列在「降糖药（A10）」大类。同一成分因适应症不同出现在两个大类，不代表可以互换。
司美格魯肽（semaglutide）、替爾泊肽（tirzepatide）、利拉魯肽（liraglutide）、度拉糖肽（dulaglutide）、艾塞那肽（exenatide）等 GLP-1 也列在「降血糖藥（A10）」大類。同一成分因適應症不同出現在兩個大類，不代表可以互換。

Theme collection — not a claim of equivalence or interchangeability.

Related ATC classes

Active ingredients in this class

21 active ingredients 21 principios activos 21 个活性成分 21 個有效成分

Subclass

How to read this list

Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.

A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.

Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.

Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.

Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.

ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.